Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer

计划入组 1,742 人 · 首次发布于 2003 年 1 月 27 日

Effect of Ondansetron for Withdrawal Symptoms

计划入组 31 人 · 首次发布于 2008 年 6 月 12 日

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

计划入组 102 人 · 首次发布于 2014 年 2 月 11 日

Malaria drug (Astellas Pharma Inc/TCG Lifesciences/Medicines for Malaria Venture)

Basimglurant

C₁₈H₁₃ClFN₃

Inosine(Rejuvesol)

C₁₀H₁₂N₄O₅

HCG HOSPITALS

India

UCG Georgia, LLC

United States

TCI CO., LTD.

Taiwan

Liquidia's YUTREPIA Achieves Commercial Success with $51.7M Q3 Sales, Attracting Major Biotech Fund Investment

Arbor Biotechnologies Secures $215M Series B to Advance CRISPR Gene Editing Platform

Abivax Repurchases $90 Million in Royalty Certificates, Streamlining Capital Structure Ahead of Obefazimod Commercialization